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Summary 
Background: Asthma is an inflammatory disease of the airways of the lung. There has been an 
increase in the prevalence of asthma and other allergic diseases over the past decades and, due 
to its high prevalence, it is of major public health concern. The reasons for this increase are still 
largely unknown, but interactions between various types of environmental exposures in 
populations with different genetic backgrounds have been proposed. Complicating matters, 
childhood asthma is not one disease but rather a syndrome characterised by several distinct 
wheezing phenotypes, rendering research even more challenging. The best way to research risk 
and protective factors is with birth cohorts that follow children from birth over the first years 
of their life, allowing temporal sequence of exposure and the development of asthma or allergic 
diseases to be analysed.  
Aim: The aim of the present thesis was to achieve an overview of birth cohorts on asthma and 
allergic diseases; to investigate potential risk and potential protective factors for the 
development of asthma in childhood; and to determine whether a tool to help monitor children 
with respiratory diseases throughout their life would be necessary and helpful.  
Methods: The overview of birth cohorts was achieved with a systematic PubMed search of all 
existing birth cohorts on asthma and allergic diseases. Vitamin D was investigated as a potential 
protective factor within the Protection against Allergy-Study in Rural Environments 
(PASTURE) birth cohort, which is an ongoing observational birth cohort on the development 
of allergic diseases in 5 European countries. Over 1,100 pregnant women were enrolled and 
their offspring is being followed up to the age of 6 years. 
Allergic rhinitis was investigated as a potential risk factor within the German Multicentre Atopy 
(MAS) study which is another observational birth cohort on the development of atopic diseases 
in early childhood in five German cities. Over 1,300 children were followed from birth to the 
age of 13 years.  
Lung function reference equations were developed using data from the LuftiBus project, 
(Germany, Switzerland, Austria, Finland and France)which is a mobile bus equipped with flow-
sensing spirometers that tours the greater Zurich (Switzerland) area and offers spirometry 
measurements to the general population. Spirometry data are recorded electronically along with 
data on basic health and lifestyle information.  
Results: An overview of birth cohorts on asthma and allergic diseases with special emphasis 
on risk and protective factors is presented.  
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Within the PASTURE cohort, vitamin D supplementation during pregnancy was shown to 
increase cord blood mRNA levels of Immunoglobulin-Like Transcripts (ILT)3 and ILT4, which 
are two inhibitory receptors on tolerogenic dendritic cells. This finding may point towards an 
early induction of tolerogenic immune responses by maternal vitamin D intake, potentially 
influencing the prenatal immune system and possibly the development of atopic diseases.  
Within the MAS cohort, allergic rhinitis in preschool children was shown to be a predictor for 
subsequent wheezing onset. Preschool children with rhinitis might thus benefit from early 
assessment of allergic sensitization to identify the children at high risk of wheezing. 
Within the LuftiBus project, the lung function data allowed the development of spirometry 
reference equations for a central European population between 8 and 90 years of age that can 
be implemented in a wide range of clinical settings. 
Conclusion: During the last decades many risk and protective factors for the development of 
asthma were identified but only a few have enough evidence to issue population based 
recommendations. As protective factor, vitamin D supplementation during pregnancy may 
influence the prenatal immune system and play a role in the development of atopic diseases. As 
risk factor, allergic rhinitis was found to be a precursor for subsequent wheezing onset. Both 
factors can be influenced and prospective studies are needed to determine whether they may 
change the prevalence of asthma and other allergic diseases. The spirometry reference equations 
developed are a useful tool for clinicians working in central Europe and following patients over 
years. As they spans across all ages they are practical to track disease progression from 
childhood to adulthood and assess effectiveness of therapy over time. 
The PhD thesis allowed a few more insights to be added to the complex entity of respiratory 
diseases in childhood, helping to understand risk and protective factors. The spirometry tool 
developed may help clinicians monitor children with respiratory diseases throughout their life.  
In the years to come, more research is needed to determine whether the protective and risk 
factors studied can be influenced and whether their alteration has any effect on the incidence of 
asthma.  
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Chapter I: General introduction and background 
Asthma is a chronic inflammatory disease of the airways of the lung that causes recurrent 
episodes of breathlessness, cough, wheezing and chest tightness in susceptible individuals. [1]. 
It is a heterogeneous condition with variable signs and symptoms in patient groups, as well as 
variability within each individual patient over time [2]. Small children begin with wheezing 
symptoms, and, based on the time of onset, the different risk factors and determinants, the 
wheezing either resolves or can progress into asthma and may persist into adulthood [2]. Taking 
into account these different phenotypes, it can be postulated that asthma may not be one disease 
but rather a syndrome and that distinct mechanisms underlie the apparently equivalent clinical 
manifestations. Current asthma therapies are effective in cases of mild asthma, but severe 
asthma remains very difficult to treat. Around 80% of the cost arises from the 20% of 
individuals with severe disease. According to the Asthma and Allergy Foundation of America, 
asthma is among the most common chronic condition of children, producing the greatest 
number of school absences, and is the third ranking cause of childhood hospitalization [3]. In 
Europe around 30 million adults and children suffer from asthma [4]. In 2007, the total 
incremental cost of asthma to society in the USA was estimated at $56 billion, with productivity 
losses caused by morbidity accounting for $3.8 billion and productivity losses caused by 
mortality accounting for $2.1 billion [5]. 
Epidemiology of childhood asthma  
The fact that the prevalence of asthma and allergic diseases increased at a higher than expected 
rate over the past 40-50 years [6-8] resulted in a great amount of research, mainly due to the 
public health concerns of this intriguing phenomenon.  
In 1976 Gerrard et al. proposed that it was “the price to be paid by the white community …for 
their relative freedom from diseases due to viruses, bacteria and helminths” [9] and in 1989 
Strachan introduced the idea of the nowadays well known hygiene hypothesis, after observing 
a decreased risk of hay fever with increasing birth order [10]. The initial definition of the 
hygiene hypothesis has since been broadened, because of the observation that the 
“industrialized way of life” at large, with its reduced microbial exposure, may be responsible 
for the increased prevalence of atopic diseases. As a result, an increasing number of studies 
were performed, focusing not only on risk but also on protective factors for the development of 
atopic diseases and asthma with the aim of finding the cause of the diseases and the reason for 
their increase. Research groups have focused on understanding their onset, their risk and 
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protective factors, their pathogenesis and finally on finding treatments [11]. However, after 
decades, the reasons for the increase are still largely unknown, but interactions between various 
types of environmental exposures in populations with distinct genetic backgrounds have been 
proposed [7].  
Research has focused on a number of environmental contributors such as stress [12], nutrition, 
[13] or second-hand smoke [14] to name a few, but also on the lung [15] or the immune system 
[16] development or on genetic factors [17]. Achieving an overview of the potential causes for 
the development of asthma is challenging but was one of the aims of the present dissertation.  
Types of studies 
The study of any disease begins with its description, the identification of the population at risk 
and the disease’s natural history. Epidemiology then aims at uncovering the intrinsic and 
extrinsic determinants of the disease [11].  
Research often starts with cross sectional studies which allow the identification of risk and 
protective factors. Cross sectional studies measure simultaneously the prevalence of exposures 
and diseases in a given population. They are useful to generate hypotheses but cannot 
definitively give answers on a time sequence between a potential risk or protective factor and a 
disease. The advantage of cross sectional studies is that they can be done in a short period of 
time with, potentially, very large populations.   
Prospective studies have the advantage of documenting temporal sequences, meaning that the 
cause precedes the disease begin. Conclusions on causal relations are thus facilitated. Typically, 
a group of individuals is recruited before the onset of a disease and they are followed commonly 
for years. The incidence of the disease is then documented. These groups of individuals are 
commonly called cohorts and the studies, cohort studies. A cohort can be drawn from a general 
population or a population at high risk of developing the disease. Recruiting high risk 
populations reduces the number of individuals needed, increases the participation rate of the 
probands thus reducing the cost of the study.  
Cohort studies can be either observational or interventional. An observational cohort study is 
an epidemiologic study of subjects who are exposed in different degrees to a risk or protective 
factor hypothesized to influence the occurrence of a given disease or outcome. The probands 
are followed over a period of time and the natural evolution of the disease is observed. The 
study can either observe one population or different populations in parallel (farmers vs. 
reference children [18]). In interventional cohort studies, the probands are allocated into groups 
to evaluate the efficacy and safety of a preventive or therapeutic regimen. At least one group is 
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left to its natural course and is used as a control. The probands are then followed for a given 
period of time [19]. The term birth cohort study is generally used to describe a cohort in which 
children are either recruited pre- or post-nataly and observed over the next years to examine 
associations between early-life exposures and childhood outcomes. 
The advantage of cohort studies is the discovery of risk and protective factors, the disadvantages 
are the cost of the follow-up and the years necessary for the study completion both on the 
probands and on the researcher’s side. Additionally a proper randomization and double blinding 
is not always possible, often for ethical reasons (randomized studies on parachute use to prevent 
death and major trauma is not possible [20])  
Vitamin D and the immune system  
The idea of dietary manipulation to prevent a disease is interesting as it would be a simple and 
cheap manner to influence health. Additionally, many nutriments ingested by mothers cross the 
placenta and may, therefore, influence the child prenatally. Vitamin D has gained interest in 
asthma research as it has been associated with disease control [21, 22] and disease prevention 
when taken during pregnancy [23].  
Vitamin D is also known to have strong immunomodulator properties inducing tolerogenic 
dendritic cells. Dendritic cells are specialized antigen-presenting cells of the immune system 
that process antigen material and present it on the cell surface to the T helper (Th) cells [24]. In 
response to the antigens, the T helper cells communicate with B cells to mediate appropriate 
immune responses. Immunoglobulin-Like Transcripts (ILT)3 and ILT4 are two inhibitory 
receptors that can be up-regulated on tolerogenic dendritic cells in response to external 
stimulation [25] (Fig. 1). After up-regulation of ILT3 and ILT4, a possible pathway in which 
dendritic cells influence T cells is by the enhanced secretion of Interleukin (IL)-10 [26, 27].   
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Figure 1: Proposed action of ILT3 and ILT4 on the immune system 
CD: Cluster of Differentiation; DC: dendritic cells; ILT: Immunoglobulin-Like Transcripts; IFN-
α: Interferon alpha; IL: Interleukin; T: T cell; Th: T helper cell; TGF-β: Transforming growth 
factor; Treg: T regulatory cell 
 
Whether the effect of vitamin D on the development of allergic diseases is mediated by 
tolerogenic dendritic cells or through the enhanced secretion of IL-10 is unknown. 
Rhinitis and the united airway concept  
Allergic rhinitis is clinically defined as a symptomatic disorder of the nose induced after 
allergen exposure and mediated by an immunoglobulin E (IgE) inflammation of the membranes 
lining the nose [28]. It was defined in 1929 by Hansel as “The three cardinal symptoms in nasal 
reactions occurring in allergy are sneezing, nasal obstruction and mucous discharge” [29]. The 
link between upper and lower respiratory tracts has been observed in the past decades but only 
studied during the last years [30]. Particular attention has been paid to the relationship between 
rhinitis and asthma, i.e. between the upper and lower inflammation of the airways. The 
increasingly detailed knowledge of the mechanisms sustaining allergic inflammation in the 
respiratory tract (i.e. antigen presentation, cytokines, chemokines and adhesion molecules) have 
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partly clarified the functional relationships between nose and bronchi. Therefore, it is logical to 
expect that allergy is not a disease of a specific target organ, but rather a disorder of the whole 
respiratory tract with a broad spectrum of clinical manifestations [30]. These observations lead 
to the “united airways concept” which suggests that the respiratory system functions as an 
integrated unit. Mostly adult studies have suggested that there may be a causal effect between 
rhinitis and asthma [31], with the former being a risk factor the later. Studies in children on a 
link between rhinitis and asthma are sparse and in small children lacking. Complicating matter, 
in early childhood, there are several wheezing phenotypes, with some resolving after a few 
years but some persisting into adulthood [32]. However, by the age of six years patterns of 
wheezing prevalence and levels of lung function appear to be established and seem to track to 
adulthood [33, 34]. The idea of a risk factor, such as rhinitis, in early childhood that could 
possibly alter these patters is tempting and warrants further research.   
Lung functions to track disease progression  
Establishing a diagnosis of asthma involves a careful process of history taking, physical 
examination and diagnostics especially in the pediatric population. Once a diagnosis is 
confirmed, disease progression needs to be monitored, often over years. Lung functions are 
used for the diagnosis and the monitoring of patients with asthma. Their interpretation relies on 
the comparison of data from the patient with reference values based on healthy subjects from a 
general population. Reference values should be obtained from studies of “normal” or “healthy” 
subjects with the same anthropometric (e.g. sex, age and height) and, where relevant, ethnic 
characteristics of the patient being tested and should not be extrapolated beyond the published 
age-range [35]. Such reference equations are hard to obtain as most reference equations are 
either outdated, derived from a different population or do not span across all ages [36, 37]. 
Additionally, a major challenge in reference equations are the complex statistical models 
needed to develop them, as there is a steep increase of lung function throughout childhood, 
followed by a regular decline until old age [38]. Therefore, most studies have published 
reference equations either for children or for adults. However, in every day practice, reference 
equations spanning across all ages, including the transition point from childhood to adulthood 
would be of great use.  
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Aims of the present PhD 
 
 
 
 
 
In particular, the following research questions were addressed:  
1. What are the known risk and protective factors for the development of childhood 
asthma. 
2.  What questions still remain to be investigated? 
To answer those questions, an extensive research was performed in PubMed with words such 
as “birth cohorts” and “asthma”, “childhood asthma”, “asthma development”, “risk factors for 
asthma development” or “protective factors for asthma”. The results are presented in chapter 
III. 
Among other health benefits, maternal vitamin D intake during pregnancy has been associated 
with a reduced risk of wheeze in early childhood. One next research step is to determine which 
pathway is used, as this may lead to a better understanding of the protective mechanism and 
bring us one step closer to a treatment possibility. Therefore, in chapter IV, the following 
questions were addressed:  
3. Does vitamin D supplementation during pregnancy influence the immune system of the 
new born child, specifically the mRNA levels of ILT3 and ILT4? 
4. Is the effect of vitamin D mediated by IL-10? 
Rhinitis, which is a disease of the upper airways, has been shown to be a predictor for adult-
onset asthma, but whether this is true for childhood wheezing is not known. Rhinitis would 
therefore be a risk factor and its treatment could potentially lead to a diminution of the number 
of children developing asthma. In chapter V, three specific questions were addressed:  
5. What are the temporal sequences of the development of rhinitis and wheezing? 
6. Does sensitization play a role in the development of rhinitis and wheezing? 
7. Is rhinitis a risk factor for wheezing onset in children? 
The overall aim of the thesis was to achieve an overview of risk and protective factors in birth 
cohorts on asthma; and, among the abundance of them, to analyse two different ones in 
separate ongoing observational birth cohorts.  An additional aim was to determine whether a 
tool could be developed to help children with asthma.  
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Once children develop asthma, they need regular clinical follow-up over years. Lung function 
measurements help clinicians manage the asthma. Their interpretation relies on reference 
equations that need to be as similar to the patient tested as possible. 
8. Are there such reference equations for Central European children and adults? 
9. If not, is it possible to develop practical ones that can be used by clinicians in their daily 
practice?  
These questions were addressed in chapter VI.  
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Chapter II: Methods 
Overview of birth cohort studies 
For the overview of birth cohorts studies on asthma a PubMed search was performed. From the 
reference section of the papers identified additional cohorts were found, which finally gave an 
extensive overview of the existing cohorts. After studying the papers selected, an overview was 
attempted and is presented in chapter III.  
The Protection against Allergy-Study in Rural Environments (PASTURE)  
The PASTURE study is funded through a European Commission Framework 5 grant and is 
composed of a multidisciplinary team of clinicians, epidemiologists, immunologists, experts in 
genetics and microbiologists from 6 European countries. It’s main aim is to investigate the 
temporal sequence of immunological and genetic mechanisms involved in the determination of 
individual responses to environmental influences leading to the development of allergies [18]. 
It is a longitudinal birth cohort study in rural areas of 5 European countries (Germany, 
Switzerland, Austria, Finland and France). Over 1’100 pregnant women were enrolled and their 
offspring are currently being followed up to the age of 6 years.  
Exposure assessment: The main exposure categories are identified through comprehensive 
questionnaires and interviews. Sources of exposures such as stables, stable animals, barns, 
fodder, farm milk, harvesting etc. were assessed in great detail through interviews. Potential 
confounding factors such as socio-economic status, family size, maternal smoking, and the 
family history of allergic illnesses were also asked. Blood sampling was performed for genetic 
polymorphism and immunological studies. Dust, milk and stool samples were collected. 
Measures of microbial exposures such as levels of endotoxin from gram negative bacteria and 
extracellular polysaccharides from fungi were performed and will also serve as reference for 
the questionnaire/ interview assessed exposures. Immunologic pathways are being investigated.  
Outcome assessment: The incidence of asthma, hay fever and atopic eczema are assessed via 
standardized interviews to the parents. The cumulative incidence of symptoms of the respective 
diseases is the main outcome variable. In addition, a physical examination of the children at age 
1, 4.5 and 6 years is available as objective outcome measures. Allergic sensitisation was defined 
as the presence of specific IgE antibodies towards inhalant and food allergens in the serum at 
ages 1 and 4.5 years.  
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The German Multicentre Atopy (MAS-90) study 
The MAS study, an observational birth cohort, followed children from birth until 13 years old. 
Its main aims were to evaluate the predictive value of various clinical and immunological 
parameters as well as the significance of early environmental exposures to allergens and trigger 
factors for the development of atopic diseases in early childhood [39].  
A questionnaire on atopic diseases, symptoms, as well as sociodemographic variables was 
distributed in the delivery wards to the parents of infants born in 5 German cities (Berlin 
Düsseldorf, Freiburg, Mainz, München) between the 1.1. and the 31.12.1990. For the parents 
who accepted the study cord blood IgE was determined. A total of 1’314 children were recruited 
into the study, 499 new-borns with risk factors for atopy and 815 newborns with no atopy risk 
factors. Regular follow-up visits were organized when the children were 1, 3, 6, 12, 18, 24 
months and then yearly until the age of 13 years.  
Exposure assessment: At the controls questionnaires were completed on a number of subjects 
such as health symptoms, nutrition, development, environmental factors, housing conditions, 
psychological problems and demographic features. Additionally parents kept a diary in which 
details of the infant’s diet, diseases and important events were recorded. The infants had a 
standardized physical examination by a physician with special emphasis on skin conditions. 
Carpet dust samples were analysed for allergens at 6, 18 and 36 months of age. Blood samples 
were taken at 12 and 24 months for the determination of total IgE against 9 common food and 
inhalant allergens. Spot urine samples for cotinine determinations were collected at 12 and 24 
months of age. 
Outcome assessment: Clinical manifestations of atopic diseases and atopic sensitisation were 
treated separately. The diagnosis of the family physician, of the examining doctor and, 
additionally, a statistical analysis of the relevant symptoms or signs were used to define an 
obvious or probable atopic manifestation in the first 24 months of life. Consistent vomiting, 
diarrhoea and colic without infection after consumption of allergenic foods, were regarded as 
symptoms and signs for food intolerance. The child was considered sensitized, when the IgE 
antibody concentration against at least 1 of 9 common allergens was higher than 0.35 kU/1. 
The LuftiBus project 
In an effort to improve health care in the Zurich metropolitan area, the ongoing „LuftiBus“ 
project was initiated in 1993 as a joint venture between the Zurich Lung Association and the 
Medical Society of Zurich [40] („LuftiBus“ may be translated into “AirBus”).  The bus tours 
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the Zurich area allowing the population to have their lung function tested. It can either be 
encountered in random public places in the greater Zurich area or be leased by schools, sport 
teams/events or any other given group. In the first case, passers-by pay a fee of 10 Swiss Francs 
for adults and 5 Swiss Francs for children (half the cost of a light meal) to get their lung function 
tested. If the bus is leased, the test and the counselling are free of charge for all participants. 
The bus is equipped with two computer assisted spirometers that allow accurate lung function 
measurements to be performed. Specially trained lung function technicians perform the 
spirometry, instruct and supervise the people being tested, and subsequently counsel them. 
After the spirometry tests have been performed, the participants receive a comprehensive report 
of their lung function results, are advised to get professional medical advice when the results 
are pathological (i.e. FEV1%pred <80%) and are shortly counselled on general health as well 
as specific pulmonary issues. Additionally, the „LuftiBus“-team collects epidemiological and 
basic health data from each person tested. Subsequently, all results are rendered anonymous 
and entered into a general database from where they can be extracted for statistical analysis. As 
of 1998, the „LuftiBus“ team has been active in children and adolescents health care prevention 
and has therefore actively gone to schools and youth events.  
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Chapter III  
 
 
Birth Cohort Studies for Prevention of Allergy, New Perspectives, 
where do we go from now? 
 
 
 
 
This book chapter has been published:  
Rochat MK, von Mutius E. Birth Cohort Studies for Prevention of Allergy, New Perspectives, 
where do we go from now?   
In: Springer, editor. Allergy Frontiers: Therapy and Prevention. Japan: Springer; 2010. 
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Chapter IV  
 
 
Maternal vitamin D intake during pregnancy increases gene 
expression of ILT3 and ILT4 in cord blood 
 
 
 
 
This article has been published:  
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Allergy 2010 May;40(5):786-94. 
 
 
 
 
 
 
 
 
38 
  
39 
  
40 
 
41 
 
42 
 
43 
 
44 
 
45 
 
46 
 
47 
Chapter V  
 
 
Allergic rhinitis as a predictor for wheezing onset in school-aged 
children 
 
 
 
This article has been published:  
Mascha K. Rochat, Sabina Illi, Markus J. Ege, Susanne Lau, Thomas Keil, Ulrich Wahn, Erika 
von Mutius, and the Multicentre Allergy Study (MAS) group, Allergic rhinitis as a predictor 
for wheezing onset in school-aged children, Journal of Allergy and Clinical Immunology, 2010 
Dec;126(6):1170-5.e2 
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Chapter VI  
 
 
Spirometry Reference Equations for Central European Populations 
from School Age to Old Age 
 
 
 
This article has been published:  
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Wildhaber J.  Spirometry reference equations for central European populations from school age 
to old age. PLoS One. 2013;8(1):e52619. 
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Figure S1 Residual plots for FEV1 from the GAMLSS model 
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Figure S2 Worm plot of the residuals of the GAMLSS reference equation for 
FEV1  
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Figure S3 Formula for calculating quantiles 
 
 
 
 
 
 
 
 
 
Figure S4 Residual plots for FEV1 for quantile regression 
Figure S5 Comparison between the GAMLSS and Quantile Regression 
reference equations 
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Chapter VII: General discussion and outlook  
General aspects of the results from the birth cohort chapter 
To begin, a summary of the main findings of the book chapter is presented which answers the 
first question of the thesis, namely:  
1. What are the known risk and protective factors for the development of childhood asthma? 
In observational as well as interventional birth cohorts on asthma or allergies two major topics 
have been investigated in the last years: nutrition and environmental factors.  
Nutritional factor studies have concentrated on maternal diet, breastfeeding, infant formula and 
the introduction of solid foods. Most studies were done in high risk children, many of these 
studies were observational and some interventional studies could not be done in a proper 
randomised way for obvious ethical reasons (breastfeeding). Taken together, no effect could be 
seen on the development of allergic diseases except for the introduction of solid food after the 
4th month and probiotics given to pregnant mothers and their children for the first few months 
after birth.  Therefore, to be able to make recommendations, interventional studies with proper 
randomization, following children into childhood or even adolescence would be needed.  
Research on environmental factors have focussed on a number of subjects such as 
environmental tobacco smoke, traffic pollution, house dust mites, pet exposure, family size or 
early day care, infections, microbial exposures or medication. From all these studies only 
environmental tobacco smoke can be conclusively seen as a risk factor for the development of 
asthma.   
Even multi-faceted studies, which have tried a combination of avoidance of known risk factors 
and promotion of protective factors, have not been able to pin-point a combination of factors 
that show conclusive evidence on the development of asthma. Additionally, studies on 
secondary or tertiary prevention were not able to influence the disease outcome. 
 
This brings us to the second question of the thesis, namely:  
2. What questions still remain to be investigated? 
Although the huge body of research on risk and protective factors seems rather disappointing 
as only few recommendations can be made and disease incidence cannot yet be influenced, the 
birth cohort studies have contributed substantially to the understanding of the natural course of 
allergic diseases. And, even though consistency across populations is often lacking, they have 
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identified a number of potential harmful and protective determinants, allowing the research 
community to identify targets for treatment and preventive strategies. Nevertheless, these 
hypothesis-generating observations must be validated with carefully designed interventional 
birth cohorts before population based recommendations can be made.  
Window of opportunity 
Although different birth cohorts often have contradictory results an increasing amount of 
research points towards a sensitive window of opportunity during pregnancy and early 
childhood [3]. While genetic background, allergic status of parents, and predisposition for atopy 
and inflammation play an important role, prenatal and early childhood environmental 
conditions seem to be able to alter the course of the immune and respiratory system 
development and thus influence the incidence of asthma [3]. The respiratory and immune 
systems are functionally immature at birth and undergo prolonged periods of pre- and postnatal 
development and, as such, are vulnerable to a variety of environmental exposures [41]. The 
environmental influence may be mediated by alterations that maintain the Th2 bias seen during 
gestation, blocking the maturation of innate immune cells and creating inflammatory 
dysfunction in the infant that may provide the foundation for childhood asthma [3]. A potential 
way to achieve conclusive evidence would thus be to concentrate future research on this 
sensible time period, following the children subsequently until adulthood.  
Gene-environment interaction 
The observational and interventional birth cohort studies reported in the book chapter did not 
investigate gene-environment interactions. As mentioned in the introduction, asthma is a 
complex disease, and its incidence is probably determined by an interplay of genetic and 
environmental factors [42]. There are possibly many genes with small effects that interact with 
a person’s environment and determine the incidence of asthma [42]. Many studies have linked 
genetics to characteristics of asthma helping to identify risk factors for specific phenotypes of 
asthma [43], but gene-environment interactions introduce complications into these studies [44]. 
Complicating matters even more, recent studies have not only found gene-environment 
interactions, but also environment-environment interactions (Table 2 in [3]). To be able to, not 
only take gene-environment, but also environment-environment interactions into consideration, 
future research would need to include an interdisciplinary group of researchers and a big 
research population. This challenging task, however, may give an insight into the development 
of asthma.  
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Conclusion 
Because asthma is connected to the risk of several comorbid chronic conditions, the benefit of 
asthma risk reduction and prevention is greater than may be initially apparent. 
No single risk factor can fully explain the increased prevalence of asthma in recent decades but 
it is assumed that the rapid increase is due to environmental and/or epigenetic changes [3]. 
Research, therefore, should not focus on individual factors, genes or pathways but on the 
combination of host, social and environmental factors in both disease inception and control 
[11]. To achieve this, large, interventional, longitudinal studies following children into 
adulthood, involving many research areas would be necessary.  
General aspects of the results from the vitamin D study 
To begin, a summary of the main findings of the paper is presented which answers the two 
following thesis questions:  
3. Does vitamin D supplementation during pregnancy influence the immune system of the new 
born child, specifically the mRNA levels of ILT3 and ILT4? 
Maternal vitamin D supplementation during pregnancy was found to increase significantly gene 
expression of ILT3 and ILT4 in cord blood. The immune system of the new born can therefore 
be influenced by maternal food intake. Their increase may point towards an early induction of 
tolerogenic immune response. However, whether cord blood ILT3 and ILT4 mRNA levels are 
of relevance for the allergy risk later in life is unclear. 
4. Is the effect of vitamin D mediated by IL-10? 
ILT3 and ILT4 mRNA levels were found to be inversely associated with IL-10 production after 
stimulation. This finding is contrary to what could be expected and should be interpreted with 
caution as it contradicts other studies.  
 
The potential effect of maternal supplementation of vitamin D on the new born immune system 
is an interesting hypothesis and the results of the paper do seem to point towards an association. 
However, there are several aspects that need to be taken into consideration: 
Maternal vitamin D 
In the PASTURE study, maternal vitamin D supplementation was assessed via a questionnaire 
completed by pregnant mothers in their third trimester, as the serum (blood component) 
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concentrations were not available. The question inquired about current vitamin D intake: ‘Do 
you currently take any vitamin, minerals or other dietary supplements? Vitamin D yes/no.’ 
Very little is currently known about the effect of vitamin D on the immune system of an unborn 
child. The results of the paper raise a series of research questions, namely:  
- At what stage does vitamin D affect the immune system?  
- Is there a window of opportunity where the immune system is particularly sensitive to 
vitamin D influence (eg. in early or late pregnancy [45])?  
- Is vitamin D deficiency a risk factor, or are high doses protective against allergic 
diseases?  
- Is there a dose-response effect of maternal vitamin D supplementation on cord blood 
dendritic cells?  
Answers to these questions would necessitate serial measurements of maternal serum vitamin 
D throughout pregnancy and up until the time of birth. Such measurements were not done in 
our study and could be suggested for future research.  
In our study, only two populations recommend vitamin D supplementation during pregnancy 
(France and Finland), and those countries do not recommend a daily dose during the whole 
year. Due to the type of question asked (see above), the number of women supplementing 
vitamin D during pregnancy was potentially underestimated. Additionally, there are three 
sources of vitamin D: diet, supplements and sunlight [46]. As it was not possible to assess all 
sources of vitamin D in the PASTURE study, different questions might have given different 
prevalence’s and thus different results. 
The role of IL-10 
In our study the potential effect of vitamin D on the new born immune system was not mediated 
by the cytokine IL-10 which is an astonishing result as it has been shown that 1,25(OH)2D-
treated human dendritic cells have the capacity to convert CD4 T cells into IL-10–secreting 
Treg cells and suppress the proliferation of T cells [47]. The PASTURE study is not specifically 
designed to evaluate the effect of vitamin D on the new born immune system [18] which is the 
reason why IL-10 levels were not measured directly after exposure to vitamin D as in other 
studies [48]. Rather, the cellular capacity to produce IL-10 was measured after stimulation with 
phorbol 12-myristate 13-acetate and ionomycin (P/I). To answer the question of whether the 
vitamin D effect is mediated by IL-10, future research on the subject, should be made with 
direct blood measurements of both vitamin D and IL-10.  
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The effect of tolerogenic dendritic cells on the development of asthma 
Beyond a central role in calcium and bone physiology, vitamin D metabolism (specifically the 
conversion of 25(OH)D to the active form vitamin D (1,25[OH]2D)) has effects on epithelial 
cell, T-cell, B-cell, and dendritic cell functions that are important to innate and adaptive 
immunity [49]. Although tolerogenic dendritic cells are interesting candidates for the pathway 
in which vitamin D could influence the development of asthma, there are other mechanisms 
that are just as plausible [46]. Therefore, whether the results correlate with asthma incidence 
needs to await  data from the cohort in a few years, when the children will, or will not, have 
developed asthma.   
Conclusion 
The hypothesis generated by the results in our paper are interesting but do not allow for 
definitive conclusions to be made. Future research is necessary to determine whether maternal 
serum vitamin D levels during pregnancy are associated with tolerance induction of the neonatal 
immune system and whether this association can be extended to disease manifestation in 
school-age children. Due to the complexity of the pathogenesis of asthma, the questions would 
require collaborative work among clinicians, epidemiologists, immunologists, and geneticists 
and would have to be done in an interventional, randomized, double blind birth cohort study. 
The results could help understanding the immunological mechanism of vitamin D on the 
maturing human immune system. The implications could open new avenues into the 
development of preventive, diagnostic and therapeutic strategies to reduce the burden of asthma 
and allergies.  
General aspects of the results from the rhinitis study 
To begin, a summary of the main findings of the paper is presented which answers the three 
following thesis questions:  
5. What are the temporal sequences of the development of rhinitis and wheezing? 
Rhinitis point prevalence was highest at 3 years with 9.2% and ranged between 2.5% and 7.7% 
throughout the other years. By the age of 13 years, the cumulative incidence of rhinitis was 
47.8%. Wheezing point prevalence was highest at the end of the second year with 19.8%, 
decreasing to less than 7% throughout the following years. The cumulative incidence of 
wheezing was 40.5% by the age of 13 years. Although both clinical manifestations appear 
during the first years of life, rhinitis was not associated with wheezing during the first two years 
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of life, but significantly predicted the incidence of wheezing by the age of 5 years, whereas 
wheezing was not a predictor for the incidence of rhinitis at either 2 or 5 years.  
6. Does sensitization play a role in the development of rhinitis and wheezing?  
Independent of the age considered, sensitization was a predictor for the incidence of wheezing 
and rhinitis. At the age of two years, sensitization to any allergen influenced the period 
prevalence of wheezing. By the age of 5 years, allergic rhinitis was associated with the highest 
period prevalence of wheezing, and non-allergic rhinitis showed significantly higher period 
prevalence’s than atopy without rhinitis. 
7. Is rhinitis a risk factor for wheezing onset in children? 
The findings of the paper suggest that allergic rhinitis in preschool children is a risk factor for 
subsequent wheezing onset. In contrast, neither the rare manifestation of allergic rhinitis in the 
first two years of life nor non-allergic rhinitis up to the age of five years was associated with 
the onset of wheezing in childhood. Therefore, some childhood wheezing phenotypes are 
associated with rhinitis. Additionally, the discrepancy between the cumulative incidence of 
rhinitis (47.8%) and its peak period prevalence at the age of 3 years (9.2%) suggests that rhinitis 
is a transient phenomenon in early childhood and manifests years before wheezing begins. 
Thus, the findings of the paper strongly suggest that a progression from rhinitis to wheezing 
can be found.  
 
Rhinitis in preschool children was found to increase the risk of wheezing in preschool children. 
Wheezing is often a precursor to asthma, and asthma is a major risk factor for chronic 
obstructive pulmonary diseases (COPD) [50]. Given the importance of the finding of a potential 
risk factor, a few questions should be considered:   
Mechanism for the progression from rhinitis to wheezing 
As discussed in the paper, there are several potential mechanisms that might explain the 
association found between rhinitis and wheezing. Elucidating the exact mechanism could help 
understand the disease progression, pin-point windows of opportunity and aid in targeting 
specific therapies to either slow down or halt the progression. Therefore, major areas of future 
research might concentrate on similarities in histological structures, inflammatory mechanisms 
and anatomical proximity [29]. 
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Secondary prevention of allergic rhinitis 
The fact that allergic rhinitis in preschool children was found to be a risk factor for wheezing 
onset in childhood is, of course, appealing as it opens the possibility for secondary prevention. 
Secondary prevention has been tried in older children as allergic rhinitis is a known risk factor 
for the development of asthma in school children and adults. One of the concepts tried is 
immunological intervention [51]. The concept is to downgrade the overall propensity of the 
immune system to produce Th2-skewed responses to environmental and innocuous antigens 
[52]. This interesting prevention strategy is not allergen-specific as it influences the overall 
innate immune response and, as a consequence, the polarization of the adaptive immune 
responses. But research in this area has not yet been conclusive [53].  
By contrast, allergen-specific approaches have been successful in tertiary prevention, showing 
that allergic rhinitis treatment influences asthma control [54]; nasal inhaled steroid can modify 
asthma symptoms as well as airways hyperreactivity; and antihistaminic drugs can reduce the 
most relevant asthma triggers [55]. Allergen-specific immunotherapy is the only treatment 
found that can modify allergic rhinitis progress and reduce the risk of asthma in patients with 
allergic rhinitis [56]. Although these results are promising, most of the trials were open studies, 
with the control groups receiving symptomatic medication alone and with limited follow-up 
periods to assess any long-term effects [57], so clearly, more research is needed.  
Another option could be an “immunoprophylaxis of atopy” targeted at children who are either 
not sensitized or only sensitized to a few allergens but still healthy. It could be done at a very 
early age when the immune response is more susceptible to be corrected or re-addressed. The 
prophylactic intervention could even be tailored on the child’s molecular sensitization profile 
to enhance efficacy [53, 58]. The target of the intervention could be, for examples, to prevent 
the onset of seasonal allergic rhinoconjunctivitis, thus keeping the IgE response to grass pollen 
at a subclinical level. Even if rhinitis were not prevented, its onset could be delayed and its 
symptoms diminished and perhaps its progression to asthma halted. [53].  
Conclusion 
Allergic rhinitis was found to be a risk factor for the development of wheezing and asthma, and 
treating the underlying allergy may represent an attractive method for asthma prevention. This 
should be done in double-blind, placebo-controlled randomized trials to assess the preventive 
effect of the different therapies on asthma development. 
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General aspects of the results from the lung function study 
To begin, a summary of the main findings of the paper is presented which answers the two 
following thesis questions:  
8. Are there such reference equations for Central European children and adults? 
A PubMed research with words such as “lung function” and “spirometry” reference equations 
revealed that there are many spirometry reference equations for different populations of 
different age ranges, but none that span across all ages for Central European populations.  
9. If not, is it possible to develop practical ones that can be used by clinicians in their daily 
practice?  
In the paper we present spirometry reference equations for 8–90 year olds that we derived from 
a very large, cross-sectional sample of a Central European population. 
 
Once asthma has been diagnosed, the follow-up of patients is extremely important, especially 
in childhood, as any deterioration should lead to the adaptation of therapy to prevent long term 
effects as much as possible.  Lung functions are used as objective measures of control and their 
interpretation relies on reference equations. The reference equations presented in the paper have 
certain advantages and certain disadvantages that merit a short discussion.  
Complicated statistics 
While the GAMLSS method is a very good statistical method that allows modelling of data 
with skewed and kurtotic distributions, it is not easily integrated in every lung function device. 
The aim, when developing reference equations, is naturally that they be used. Although the 
paper points out how they could be applied, the authors fear that the complicated statistics will 
deter busy clinicians from integrating the reference equations in their devices. To broaden the 
spectrum of potential users, the quantile regression equations were developed. They do not 
model the data as precisely as the GAMLSS equations, but might be adopted by more clinicians. 
Regardless of the equation selected, little is known about the real life application of the 
spirometry reference equations presented in the paper. In future papers about reference 
equations, thought might be given to practical dissemination of the equations.  
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“Ideal” Reference equations 
The “LuftiBus” collected an impressive amount of spirometry data that has been used to create 
the reference equations. Nevertheless, the aim of the “LuftiBus” is not to create reference 
equations but to offer a service to the population. In that regard, the population is not selected 
to be representative, or healthy, but is probably skewed towards people who have health 
questions. Future reference equations might be derived from a healthy, representative 
population selected in view of creating reference equations.  
Conclusions and outlook  
In this thesis four chapters are presented and discussed. First, an overview of birth cohorts on 
asthma was done, second and third a protective and a risk factor for the development of asthma 
were studied and last spirometry reference equations were developed.  
Thus, the thesis added a few more insights into the complex entity of respiratory diseases in 
childhood, helping to understand risk and protective factors. The spirometry tool developed 
may help clinicians monitor children with respiratory diseases throughout their life. The 
challenge in the years to come will be to integrate all the knowledge acquired into complex 
analysis taking, not only host, social and environmental factors into consideration but also their 
interactions, to achieve a better understanding of the causes of asthma and possibly develop 
treatments and implement prevention strategies.  
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